These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2913328)

  • 1. Infused L-histidinol and cisplatin: schedule, specificity, and proliferation dependence.
    Edelstein MB
    J Natl Cancer Inst; 1989 Feb; 81(4):298-301. PubMed ID: 2913328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity, schedule, and proliferation dependence of infused L-histidinol after 5-fluorouracil in mice.
    Edelstein MB; Heilbrun LK
    Cancer Res; 1988 Mar; 48(6):1470-5. PubMed ID: 3345520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
    Warrington RC; Muzyka TG; Fang WD
    Cancer Res; 1984 Jul; 44(7):2929-35. PubMed ID: 6722819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumors.
    Stolfi RL; Sawyer RC; Martin DS
    Cancer Res; 1987 Jan; 47(1):16-20. PubMed ID: 3791203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
    Warrington RC; Fang WD
    J Natl Cancer Inst; 1985 May; 74(5):1071-7. PubMed ID: 3858576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice.
    Zaharko D; Plowman J; Waud W; Dykes D; Malspeis L
    Cancer Res; 1992 Jul; 52(13):3604-9. PubMed ID: 1617631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
    Fujimoto S
    Biol Pharm Bull; 2006 Nov; 29(11):2260-6. PubMed ID: 17077525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemia.
    Warrington RC; Fang WD
    Br J Cancer; 1989 Nov; 60(5):652-6. PubMed ID: 2803940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice.
    Warrington RC; Cheng I; Fang WD
    J Natl Cancer Inst; 1987 Jun; 78(6):1177-83. PubMed ID: 3108563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-histidinol increases the vulnerability of cultured human leukemia and lymphoma cells to anticancer drugs.
    Warrington RC; Cheng I; Zhang L; Fang WD
    Anticancer Res; 1993; 13(6A):2107-12. PubMed ID: 8297120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemias.
    Santelli G; Valeriote F
    Cancer Chemother Pharmacol; 1986; 18(2):101-4. PubMed ID: 3791555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved treatment of disseminated B16f10 melanoma in mice with anticancer drugs in combination with L-histidinol.
    Warrington RC; Fang WD
    Anticancer Res; 1991; 11(5):1869-74. PubMed ID: 1722659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of human colon carcinoma cells to anticancer drugs is enhanced by L-histidinol.
    Warrington RC; Cheng I; Fang WD
    Anticancer Res; 1994; 14(2A):367-72. PubMed ID: 8017835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma model.
    Shnyder SD; Cooper PA; Gyselinck N; Hill BT; Double JA; Bibby MC
    Anticancer Res; 2003; 23(6C):4815-20. PubMed ID: 14981930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-dependent activity of 5-fluorouracil plus tauromustine in a transplantable well-differentiated murine colon adenocarcinoma.
    Hill SR; Pollard LA; Bibby MC
    Anticancer Res; 1992; 12(6B):2169-75. PubMed ID: 1295464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of drug sequence in therapeutic selectivity of the combination of 5-fluorouracil and cis-platin.
    Palmeri S; Trave F; Russello O; Rustum YM
    Sel Cancer Ther; 1989; 5(4):169-77. PubMed ID: 2623382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination effect of recombinant human interleukin 1 alpha with antitumor drugs on syngeneic tumors in mice.
    Nakamura S; Kashimoto S; Kajikawa F; Nakata K
    Cancer Res; 1991 Jan; 51(1):215-21. PubMed ID: 1899039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of L-histidinol and homoharringtonine on 5-fluorouracil and bis-chloroethylnitrosourea activity in a murine model.
    Warrington RC; Fang WD
    Anticancer Res; 1991; 11(5):1879-83. PubMed ID: 1768059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.